Synthesis and evaluation of quinazolin-4-ones as hypoxia-inducible factor-1α inhibitors
Graphical abstract
Section snippets
Acknowledgments
We thank Paul Shinn and Danielle Van Leer for compound management, William Leister and Jeremy Smith for analytical chemistry. This research was supported by the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research, National Institutes of Health.
References and notes (10)
- et al.
Bioorg. Med. Chem. Lett.
(2010)et al.J. Pineal Res.
(2010)et al.Bioorg. Med. Chem. Lett.
(2010)et al.Clin. Cancer Res.
(2009)et al.Bioorg. Med. Chem. Lett.
(2009)et al.Biochem. Biophys. Res. Commun.
(2009)et al.Bioorg. Med. Chem. Lett.
(2009)et al.Cancer Biol. Ther.
(2005)et al.Curr. Signal Transduction Ther.
(2010)et al.Sci. China:Chem.
(2011)et al.Curr. Cancer Drug Tar.
(2010)Drug Discovery Today
(2007)et al.Cell Metab.
(2008)et al.Biochem. Pharmacol.
(2009)et al.Oncogene
(2009)et al.Mol. Cancer Ther.
(2008)et al.Mol. Cancer Ther.
(2008)et al.Expert Opin. Ther. Patents
(2011) - et al.
Mol. Cancer
(2009) - Becklin, R. R.; Chepanoske, C. L.; Pelter, J. M.; Qi, L.; Robbins, P. B.; Sahasrabudhe, S. R.; Selliah, R.; Simmons,...
- et al.
Tetrahedron Lett.
(2005)
Cited by (9)
Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II)
2015, European Journal of Medicinal ChemistryCitation Excerpt :Interruption of the HIF-1α/p300 (CBP) interaction has been shown to negatively regulate oncogene expression and tumor growth [19–22]. Thus, the therapeutic significance of the HIF system has stimulated further high-throughput- and natural product-screening approaches for its inhibition [23–31]. The screens have employed both cell-based and isolated protein approaches; the cell-based approaches have yielded compounds that act indirectly on HIF, affecting the stability of HIF system proteins or by binding the hypoxia response elements (HREs) in DNA.
H<inf>3</inf>PW<inf>12</inf>O<inf>40</inf> catalyzed synthesis of benzoxazine and quinazoline in aqueous media
2014, Cuihua Xuebao/Chinese Journal of CatalysisCitation Excerpt :2,3-Dihydroquinazolin-4(1H)-ones in particular have good biological activities and are also key intermediates for the synthesis of quinazolin-4(3H)-ones [36,37]. Several methods have been reported for the synthesis of quinazolinone and aryl-substituted quinazolinone compounds [38–66]. The one-pot three-component condensation of isatoic anhydride, aldehydes, and amines is the most convenient method for the preparation of these compounds.
Development of Hypoxia Inducible Factor-1 Small Molecule Inhibitors as Antitumor Agents
2021, Progress in Chemistry2-(Chloromethyl)-3-phenylquinazolin-4(3H)-ones as potent anticancer agents; cytotoxicity, molecular docking and in silico studies
2021, Journal of the Iranian Chemical SocietyPharmacologic targeting of hypoxia-inducible factors
2019, Annual Review of Pharmacology and Toxicology